Pain Management News

ORLANDO, Fla. — A pilot study of direct spinal cord stimulation showed promise for improving motor function in a small cohort of individuals with gait freezing in Parkinson’s disease, according to a presenter.

ORLANDO, Fla. — Managing dystonic cerebral palsy in younger populations presents unique challenges, which may be addressed with direct cerebellar implantation of a deep brain stimulation device, according to a presenter.

ORLANDO, Fla. — Although children often suffer from headache, there are few controlled trials that include this unique patient population, leaving clinicians to rely on their experience rather than data, according to a presenter.

The FDA has approved Aqneursa as an oral treatment for neurological symptoms associated with Niemann-Pick disease type C, a rare genetic disease, in adults and children weighing at least 15 kg, according to a press release.

The FDA announced in a press release that it has approved Miplyffa to treat neurological symptoms associated with Niemann-Pick disease type C in patients aged 2 years and older.

ORLANDO, Fla. — To properly address headache care gaps in rural areas, clinicians must focus on boosting access, improving health literacy and formulating simple but informative plans for medication usage, according to a speaker.

ORLANDO, Fla. — For stroke survivors, participation in preventive health behaviors, such as adhering to blood pressure medication and physical activity, depended on their outcome expectations, self-efficacy and agency, data show.

ORLANDO, Fla. — Patients with MS who developed paramagnetic rim lesions declined more rapidly, but implementing disease-modifying therapies earlier could reduce the burden of disease progression, data show.

The FDA has granted clearance to a Colorado-based medical technology company’s transcutaneous electrical nerve stimulation device for those suffering from chronic pain, according to a press release.

The FDA has accepted the resubmission of a new drug application for a novel, oral therapeutic intended to treat individuals with acute migraine, according to the manufacturer.